The Disease-Modifying Therapies of Relapsing-Remitting Multiple Sclerosis and Liver Injury: A Narrative Review
Author:
Funder
Università Cattolica del Sacro Cuore
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Psychiatry and Mental health,Clinical Neurology
Link
https://link.springer.com/content/pdf/10.1007/s40263-021-00842-9.pdf
Reference203 articles.
1. Comi G, Radaelli M, Soelberg SP. Evolving concepts in the treatment of relapsing multiple sclerosis. Lancet (London, England). 2017;389(10076):1347–56.
2. Ontaneda D, Tallantyre E, Kalincik T, Planchon SM, Evangelou N. Early highly effective versus escalation treatment approaches in relapsing multiple sclerosis. Lancet Neurol. 2019;18(10):973–80.
3. Onakpoya IJ, Heneghan CJ, Aronson JK. Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions: a systematic review of the world literature. BMC Med. 2016;4(14):10.
4. European Medicines Agency (EMA). 2018. https://www.ema.europa.eu/en/news/ema-review-zinbryta-confirms-medicines-risks-outweigh-its-benefits.
5. EASL Clinical Practice Guidelines. Drug-induced liver injury. J Hepatol. 2019;70(6):1222–61.
Cited by 31 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A case report of cladribine‐induced IgG4-associated liver injury;Acta Neurologica Belgica;2024-04-08
2. Successful switch to ofatumumab after liver injury associated with ocrelizumab treatment in multiple sclerosis: a case report;Frontiers in Neurology;2024-02-29
3. A Proposed Approach to Screening and Surveillance Labs for Patients With Multiple Sclerosis on Anti-CD20 Therapy;Neurology Clinical Practice;2024-02
4. Specific targeting of the NRF2/β-TrCP axis promotes beneficial effects in NASH;Redox Biology;2024-02
5. Delayed onset drug-induced acute liver failure associated with Glatiramer acetate use in multiple sclerosis requiring liver transplantation;Journal of Liver Transplantation;2024-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3